company background image
002099 logo

Zhejiang Hisoar Pharmaceutical SZSE:002099 Stock Report

Last Price

CN¥5.94

Market Cap

CN¥9.5b

7D

-1.0%

1Y

-17.2%

Updated

31 Oct, 2024

Data

Company Financials

Zhejiang Hisoar Pharmaceutical Co., Ltd.

SZSE:002099 Stock Report

Market Cap: CN¥9.5b

002099 Stock Overview

Operates as a pharmaceutical company in China and internationally.

002099 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Risk Analysis


Zhejiang Hisoar Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Hisoar Pharmaceutical
Historical stock prices
Current Share PriceCN¥5.94
52 Week HighCN¥7.55
52 Week LowCN¥3.91
Beta0.52
11 Month Change-7.48%
3 Month Change11.65%
1 Year Change-17.15%
33 Year Change-24.81%
5 Year Change-21.53%
Change since IPO100.22%

Recent News & Updates

Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Price Is Out Of Tune With Revenues

Sep 27
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Price Is Out Of Tune With Revenues

Does Zhejiang Hisoar Pharmaceutical (SZSE:002099) Have A Healthy Balance Sheet?

Aug 30
Does Zhejiang Hisoar Pharmaceutical (SZSE:002099) Have A Healthy Balance Sheet?

Recent updates

Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Price Is Out Of Tune With Revenues

Sep 27
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Price Is Out Of Tune With Revenues

Does Zhejiang Hisoar Pharmaceutical (SZSE:002099) Have A Healthy Balance Sheet?

Aug 30
Does Zhejiang Hisoar Pharmaceutical (SZSE:002099) Have A Healthy Balance Sheet?

Zhejiang Hisoar Pharmaceutical (SZSE:002099) Has Debt But No Earnings; Should You Worry?

May 27
Zhejiang Hisoar Pharmaceutical (SZSE:002099) Has Debt But No Earnings; Should You Worry?

Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Shares Climb 28% But Its Business Is Yet to Catch Up

Mar 03
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Shares Climb 28% But Its Business Is Yet to Catch Up

Shareholder Returns

002099CN PharmaceuticalsCN Market
7D-1.0%-1.4%0.1%
1Y-17.2%-5.2%4.1%

Return vs Industry: 002099 underperformed the CN Pharmaceuticals industry which returned -5.2% over the past year.

Return vs Market: 002099 underperformed the CN Market which returned 4.1% over the past year.

Price Volatility

Is 002099's price volatile compared to industry and market?
002099 volatility
002099 Average Weekly Movement6.3%
Pharmaceuticals Industry Average Movement7.1%
Market Average Movement7.8%
10% most volatile stocks in CN Market11.7%
10% least volatile stocks in CN Market5.3%

Stable Share Price: 002099 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002099's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19662,612Guorui Xuwww.hisoar.com

Zhejiang Hisoar Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers antibiotics, cardiovascular products, hypoglycemic products, fine chemicals, dyes, intermediates, and other products, as well as clindamycin products. It also provides pharmaceutical, dyestuff, and other related services.

Zhejiang Hisoar Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Hisoar Pharmaceutical's earnings and revenue compare to its market cap?
002099 fundamental statistics
Market capCN¥9.46b
Earnings (TTM)-CN¥369.49m
Revenue (TTM)CN¥1.94b

4.9x

P/S Ratio

-25.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002099 income statement (TTM)
RevenueCN¥1.94b
Cost of RevenueCN¥1.68b
Gross ProfitCN¥259.34m
Other ExpensesCN¥628.82m
Earnings-CN¥369.49m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.23
Gross Margin13.37%
Net Profit Margin-19.05%
Debt/Equity Ratio20.3%

How did 002099 perform over the long term?

See historical performance and comparison